ScanSource (SCSC) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
15 Jan, 2026Executive summary
Q1 FY25 net sales declined 11.5% year-over-year to $775.6M amid soft technology demand, but recurring revenue grew 18.8% and gross margin improved to 13.1% from 12.2% due to a higher recurring revenue mix.
GAAP net income rose 10% to $17.0M ($0.69/share), aided by a $5.1M insurance recovery related to a prior cyberattack; non-GAAP net income increased 11.2% to $20.8M ($0.84/share).
Adjusted EBITDA grew 2.1% to $35.7M, with margin up to 4.6%; free cash flow was $42.5M, and $28.1M was used for share repurchases.
Realigned reporting segments to Specialty Technology Solutions and Intelisys & Advisory, reflecting different sales models and margin profiles.
Closed acquisitions of Resourcive and Advantix in August 2024, expanding advisory and connectivity offerings and launching the Integrated Solutions Group.
Financial highlights
Net sales: $775.6M, down 11.5% year-over-year; organic net sales down 10.7%.
Gross profit: $101.6M, down 4.6% year-over-year; gross margin up to 13.1%.
Adjusted EBITDA: $35.7M, up 2.1% year-over-year; Adjusted ROIC annualized at 13.3%.
Free cash flow: $42.5M; cash and equivalents: $145.0M at quarter-end; net debt leverage ratio at zero.
Non-GAAP net income and diluted EPS increased 11% and 14% year-over-year, respectively.
Outlook and guidance
FY25 guidance reaffirmed: net sales $3.1B–$3.5B, adjusted EBITDA $140M–$160M, free cash flow at least $70M.
Management expects the effective tax rate for FY2025 to be approximately 28.9% to 29.9%.
Capital expenditures for FY2025 projected at $10–15M, focused on IT investments.
Cost reduction and restructuring actions in September 2024 are expected to yield $10.5M in annualized SG&A savings.
Expect a cautious tech spending environment with gradual demand improvement, anticipating a stronger second half of the year.
Latest events from ScanSource
- Recurring revenue and margin expansion drive growth, supported by disciplined capital allocation.SCSC
Investor presentation - Quarterly sales up 8.8% to $766.8M, strong cash flow, margin gains, and new business initiatives.SCSC
Q3 2026 - Recurring revenues and disciplined capital allocation drive margin growth and efficiency.SCSC
47th Annual Raymond James Institutional Investor Conference - Q2 FY26 saw 2.5% sales growth, margin pressure, and reduced full-year guidance.SCSC
Q2 2026 - Transformation to a converged hardware and recurring revenue model drives growth and margin expansion.SCSC
Raymond James TMT and Consumer Conference - Hybrid distribution and recurring revenue drive growth, with a focus on cash flow and strategic M&A.SCSC
Raymond James 2024 TMT & Consumer Conference - Sales fell but margins and cash flow improved; acquisitions and hybrid strategy support growth.SCSC
Q4 2024 - Recurring revenue now exceeds 30% of gross profit, fueling margin expansion and strategic growth.SCSC
Raymond James & Associates’ 46th Annual Institutional Investors Conference 2025 - Sales fell 15.5% but margin and recurring revenue rose; FY25 guidance reaffirmed.SCSC
Q2 2025